PATENT CLAIM ANALYSIS

Application Number: 16225920
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["514", "210200"]

Abstract:
The present invention relates to compounds of formula (I): or pharmaceutically acceptable salts thereof, as well as processes for their manufacture, pharmaceutical compositions comprising them, and their use as medicaments.

Claim (Index 35):
The compound of  claim 1 , wherein R 10  and R 11  together with the interconnecting nitrogen form azetidinyl, piperazinyl, morpholinyl, imidazolyl or pyrrolidinyl, each optionally substituted with one ore two methyl, trifluoromethyl, hydroxy, methoxy, COOH, CO-methoxy or CO-ethoxy.

Metadata:
- Claim Count in Document: 99.0
- Percentile: 98.0
- Lexical Diversity: 1.15625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12845045', '14458062', '13272079', '13519872', '12815800']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7643441923547716
- 35 USC 102 Novelty (BERT): 0.5189321189723649
- Combined Prediction Score: 0.739802985016531
- Mean Citation Score: 282.042748
- Max Citation Score: 286.458
- Similarity Product: 204.9666570857764

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test